Mechanism of T-cell mediated protection in newborn mice against a Chlamydia infection

Microbes and Infection

Volumn 15, Issue 8-9, 2013, Pages 607-614

  Pal, Sukumar ^a   de la Maza, Luis M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Chlamydia muridarum; Maternal antibodies; Neonatal immunity; Neonatal mouse model; Passive immunity

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12;

ANTIGEN PRESENTING CELL; ARTICLE; BACTERIAL IMMUNITY; CELL PROLIFERATION; CHLAMYDIA; CHLAMYDIASIS; CONTROLLED STUDY; IN VITRO STUDY; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

CHLAMYDIA MURIDARUM; MATERNAL ANTIBODIES; NEONATAL IMMUNITY; NEONATAL MOUSE MODEL; PASSIVE IMMUNITY;

ADOPTIVE TRANSFER; ANIMALS; ANIMALS, NEWBORN; ANTIBODIES, BACTERIAL; BACTERIAL LOAD; CELL PROLIFERATION; CELLS, CULTURED; CHLAMYDIA INFECTIONS; CHLAMYDIA MURIDARUM; CYTOKINES; FEMALE; IMMUNITY, MATERNALLY-ACQUIRED; LEUKOCYTES, MONONUCLEAR; LUNG; MALE; MICE; MICE, INBRED BALB C; T-LYMPHOCYTES;

ANIMALIA; CHLAMYDIA; CHLAMYDIA MURIDARUM; MUS;

EID: 84880624249     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2013.04.010     Document Type: Article

References (45)

1. Chlamydia screening among sexually active young female enrollees of health plans - United States, 2000-2007. MMWR Morb. Mortal. Wkly. Rep. 2009, 58:362-365.
2. Numazaki K., Asanuma H., Niida Y. Chlamydia trachomatis infection in early neonatal period. BMC Infect. Dis. 2003, 3:2.
3. Schachter J., Caldwell H.D. Chlamydiae. Annu. Rev. Microbiol. 1980, 34:285-309.
4. Persson K., Ronnerstam R., Svanberg L., Polberger S. Neonatal chlamydial conjunctivitis. Arch. Dis. Child. 1986, 61:565-568.
5. Brunham R.C., Laga M., Simonsen J.N., Cameron D.W., Peeling R., McDowell J., Pamba H., Ndinya-Achola J.O., Maitha G., Plummer F.A. The prevalence of Chlamydia trachomatis infection among mothers of children with trachoma. Am. J. Epidemiol. 1990, 132:946-952.
6. Darville T. Chlamydia trachomatis infections in neonates and young children. Semin. Pediatr. Infect. Dis. 2005, 16:235-244.
7. Darougar S. Prevalence of Chlamydia trachomatis infections in pregnant women and neonates. Ann. N. Y. Acad. Sci. 1988, 549:24-30.
8. Dereli D., Coker M., Ertem E., Serter D., Tanac R., Tez E. Chlamydial infection in infants. J. Trop. Pediatr. 1996, 42:233-236.
9. Levy O. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat. Rev. Immunol. 2007, 7:379-390.
10. Forsthuber T., Yip H.C., Lehmann P.V. Induction of TH1 and TH2 immunity in neonatal mice. Science 1996, 271:1728-1730.
11. Ridge J.P., Fuchs E.J., Matzinger P. Neonatal tolerance revisited: turning on newborn T cells with dendritic cells. Science 1996, 271:1723-1726.
12. Pal S., Tatarenkova O., de la Maza L.M. Maternal immunity partially protects newborn mice against a Chlamydia trachomatis intranasal challenge. J. Reprod. Immunol. 2010, 86:151-157.
13. Morrison R.P., Caldwell H.D. Immunity to murine chlamydial genital infection. Infect. Immun. 2002, 70:2741-2751.
14. Jupelli M., Selby D.M., Guentzel M.N., Chambers J.P., Forsthuber T.G., Zhong G., Murthy A.K., Arulanandam B.P. The contribution of interleukin-12/interferon-gamma axis in protection against neonatal pulmonary Chlamydia muridarum challenge. J. Interf. Cytokine Res. 2010, 30:407-415.
15. Zinkernagel R.M. Maternal antibodies, childhood infections, and autoimmune diseases. N. Engl. J. Med. 2001, 345:1331-1335.
16. Nigg C. An unidentified virus which produces pneumonia and systemic infection in mice. Science 1942, 95:49-50.
17. Pal S., Fielder T.J., Peterson E.M., de la Maza L.M. Protection against infertility in a BALB/c mouse salpingitis model by intranasal immunization with the mouse pneumonitis biovar of Chlamydia trachomatis. Infect. Immun. 1994, 62:3354-3362.
18. Caldwell H.D., Kromhout J., Schachter J. Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis. Infect. Immun. 1981, 31:1161-1176.
19. You D., Ripple M., Balakrishna S., Troxclair D., Sandquist D., Ding L., Ahlert T.A., Cormier S.A. Inchoate CD8+ T cell responses in neonatal mice permit influenza-induced persistent pulmonary dysfunction. J. Immunol. 2008, 181:3486-3494.
20. Campbell I.L., Oxbrow L., Harrison L.C. Reduction in insulitis following administration of IFN-gamma and TNF-alpha in the NOD mouse. J. Autoimmun. 1991, 4:249-262.
21. Davidson N.J., Hudak S.A., Lesley R.E., Menon S., Leach M.W., Rennick D.M. IL-12, but not IFN-gamma, plays a major role in sustaining the chronic phase of colitis in IL-10-deficient mice. J. Immunol. 1998, 161:3143-3149.
22. Lee H.H., Hoeman C.M., Hardaway J.C., Guloglu F.B., Ellis J.S., Jain R., Divekar R., Tartar D.M., Haymaker C.L., Zaghouani H. Delayed maturation of an IL-12-producing dendritic cell subset explains the early Th2 bias in neonatal immunity. J. Exp. Med. 2008, 205:2269-2280.
23. Parr E.L., Bozzola J.J., Parr M.B. Purification and measurement of secretory IgA in mouse milk. J. Immunol. Methods 1995, 180:147-157.
24. Pal S., Davis H.L., Peterson E.M., de la Maza L.M. Immunization with the Chlamydia trachomatis mouse pneumonitis major outer membrane protein by use of CpG oligodeoxynucleotides as an adjuvant induces a protective immune response against an intranasal chlamydial challenge. Infect. Immun. 2002, 70:4812-4817.
25. Palacios R. Concanavalin A triggers T lymphocytes by directly interacting with their receptors for activation. J. Immunol. 1982, 128:337-342.
26. Hawkins R.A., Rank R.G., Kelly K.A. A Chlamydia trachomatis-specific Th2 clone does not provide protection against a genital infection and displays reduced trafficking to the infected genital mucosa. Infect. Immun. 2002, 70:5132-5139.
27. Igietseme J.U., Ramsey K.H., Magee D.M., Williams D.M., Kincy T.J., Rank R.G. Resolution of murine chlamydial genital infection by the adoptive transfer of a biovar-specific, Th1 lymphocyte clone. Reg. Immunol. 1993, 5:317-324.
28. Li W., Murthy A.K., Guentzel M.N., Seshu J., Forsthuber T.G., Zhong G., Arulanandam B.P. Antigen-specific CD4+ T cells produce sufficient IFN-gamma to mediate robust protective immunity against genital Chlamydia muridarum infection. J. Immunol. 2008, 180:3375-3382.
29. Su H., Feilzer K., Caldwell H.D., Morrison R.P. Chlamydia trachomatis genital tract infection of antibody-deficient gene knockout mice. Infect. Immun. 1997, 65:1993-1999.
30. Morrison S.G., Su H., Caldwell H.D., Morrison R.P. Immunity to murine Chlamydia trachomatis genital tract reinfection involves B cells and CD4(+) T cells but not CD8(+) T cells. Infect. Immun. 2000, 68:6979-6987.
31. Farris C.M., Morrison S.G., Morrison R.P. CD4+ T cells and antibody are required for optimal major outer membrane protein vaccine-induced immunity to Chlamydia muridarum genital infection. Infect. Immun. 2010, 78:4374-4383.
32. Kohl S., Loo L.S., Greenberg S.B. Protection of newborn mice from a lethal herpes simplex virus infection by human interferon, antibody, and leukocytes. J. Immunol. 1982, 128:1107-1111.
33. Moore T., Ananaba G.A., Bolier J., Bowers S., Belay T., Eko F.O., Igietseme J.U. Fc receptor regulation of protective immunity against Chlamydia trachomatis. Immunology 2002, 105:213-221.
34. Kohl S., Loo L.S. Protection of neonatal mice against herpes simplex virus infection: probable invivo antibody-dependent cellular cytotoxicity. J. Immunol. 1982, 129:370-376.
35. Koren H.S., Amos D.B., Kim Y.B. Natural killing and antibody-dependent cellular cytotoxicity are independent immune functions in the Minnesota miniature swine. Proc. Natl. Acad. Sci. U. S. A. 1978, 75:5127-5131.
36. de la Maza M.A., de la Maza L.M. A new computer model for estimating the impact of vaccination protocols and its application to the study of Chlamydia trachomatis genital infections. Vaccine 1995, 13:119-127.
37. Zhong G.M., Peterson E.M., Czarniecki C.W., Schreiber R.D., de la Maza L.M. Role of endogenous gamma interferon in host defense against Chlamydia trachomatis infections. Infect. Immun. 1989, 57:152-157.
38. Williams D.M., Magee D.M., Bonewald L.F., Smith J.G., Bleicker C.A., Byrne G.I., Schachter J. A role invivo for tumor necrosis factor alpha in host defense against Chlamydia trachomatis. Infect. Immun. 1990, 58:1572-1576.
39. Marodi L. Neonatal innate immunity to infectious agents. Infect. Immun. 2006, 74:1999-2006.
40. Beatty W.L., Byrne G.I., Morrison R.P. Morphologic and antigenic characterization of interferon gamma-mediated persistent Chlamydia trachomatis infection invitro. Proc. Natl. Acad. Sci. U. S. A. 1993, 90:3998-4002.
41. Nelson D.E., Virok D.P., Wood H., Roshick C., Johnson R.M., Whitmire W.M., Crane D.D., Steele-Mortimer O., Kari L., McClarty G., Caldwell H.D. Chlamydial IFN-gamma immune evasion is linked to host infection tropism. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:10658-10663.
42. Cusumano V., Genovese F., Mancuso G., Carbone M., Fera M.T., Teti G. Interleukin-10 protects neonatal mice from lethal group B streptococcal infection. Infect. Immun. 1996, 64:2850-2852.
43. Nicoletti F., Mancuso G., Ciliberti F.A., Beninati C., Carbone M., Franco S., Cusumano V. Endotoxin-induced lethality in neonatal mice is counteracted by interleukin-10 and exacerbated by anti-IL-10. Clin. Diagn. Lab. Immunol. 1997, 4:607-610.
44. Yang X., Gartner J., Zhu L., Wang S., Brunham R.C. IL-10 gene knockout mice show enhanced Th1-like protective immunity and absent granuloma formation following Chlamydia trachomatis lung infection. J. Immunol. 1999, 162:1010-1017.
45. Zaghouani H., Hoeman C.M., Adkins B. Neonatal immunity: faulty T-helpers and the shortcomings of dendritic cells. Trends Immunol. 2009, 30:585-591.